Date of release: 28 April 2022
Pressure has long been mounting on EU health systems. More and more patients are affected by major non-communicable diseases (NCDs) like diabetes, cancer, cardiovascular disease, and lung illnesses while the COVID-19 pandemic has challenged the sustainability of our healthcare model. We need impactful solutions that think long term and biosimilar medicines are part of it.